Back to homepage

Tag "rituximab"

Current therapeutic strategies in connective tissue disease-related interstitial lung disease: introduction to the special issue

Authors: Gian Luca Erre MD, PhD, Arduino Aleksander Mangoni MD

This Editorial introduces the Special Issue on the efficacy and safety of current treatment strategies for patients with connective tissue disease-related interstitial lung disease, including the use of immunosuppressants, such as cyclophosphamide, mycophenolate mofetil and rituximab, and antifibrotic drugs.

More

Efficacy and safety of rituximab in the treatment of connective tissue disease-related interstitial lung disease

Authors: Caterina Vacchi PhD, Andreina Manfredi MD, Giulia Cassone PhD, Gian Luca Erre MD, Carlo Salvarani MD, Marco Sebastiani MD

This article reviews the available efficacy and safety data on the use of rituximab in the treatment of rheumatic disease-related interstitial lung disease.

More